Skip to main content
. 2020 Jun 5;17(10):1415–1427. doi: 10.7150/ijms.41980

Figure 7.

Figure 7

miR-25 inhibition exerts no effect on DOX treatment in DLBCL cells. After NUDUL-1 and TMD8 cells were co-transfected with miR-25 inhibitor or NC inhibitor, DOX (5μm) was added into the cells for 24, 48, 72 and 96 h. CCK-8 results show the cell viability changes in NUDUL-1(A) and TMD8(B) cells.